Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
Cancers | Free Full-Text | Lights and Shadows in Immuno-Oncology Drug Development
Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patient
CDISC Compliant Implementation of iRECIST and LYRIC for Immunomodulatory Therapy Trials
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria | RadioGraphics
The Radiology Assistant : RECIST 1.1 - and more
RECIST 1.1 calculator - Radiology calculators
EPOS™
Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment - Ying-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen, Chi-Liang Wang, Yu-Fen Lin, Ming-Mo Ho,
soria on Twitter: "#ENA2016 Dr seymour @theNCI @EORTC @aacr on iRECIST goals and limitations https://t.co/2TBUcpcndq" / Twitter
How to better understand iRECIST – a new wave in immunotherapeutic
The Radiology Assistant : RECIST 1.1 - and more
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics - The Lancet Oncology
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics - The Lancet Oncology
PDF) Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis | Journal for ImmunoTherapy of Cancer
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. - Abstract - Europe PMC
CDISC Compliant Implementation of iRECIST and LYRIC for Immunomodulatory Therapy Trials
ABSTRACT INTRODUCTION BACKGROUND AND HISTORY
PDF) Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
PDF) Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
The Radiology Assistant : RECIST 1.1 - and more
Paper Template
Novel oncologic therapy response criteria (iRECIST and more) - Mint Medical GmbH
Novel oncologic therapy response criteria (iRECIST and more) - Mint Medical GmbH
